Why BioNTech Stock Soared 66% in March While the Market Plunged [The Motley Fool]
BioNTech SE - American Depositary Shares (BNTX)
Company Research
Source: The Motley Fool
What happenedShares of German clinical-stage biotechBioNTech(NASDAQ:BNTX Global Market IntelligenceFor context, last month the 500(This month, BioNTech stock has sunk 5.8% through April 6, compared to the broader market's .5% gain.)Image source: Getty Images.So whatWe can attribute BioNTech stock's robust performance last month to investor enthusiasm about the company's partnership with pharmaceutical giantPfizerNYSE:PFEData by YCharts.This announcement came just a day after fellow clinical-stageModernaNASDAQ:MRNAMoving our time lens out further than a month, the chart below shows how BioNTech's stock has performed since its initial public offering (IPO) in October. It's rocketed 252% from its IPO price of $5 (see chart's footnote), which is about twice Moderna stock's 24% gain over this period. The 500 returned negative 8.5% over this same period.Now whatAt the time the Pfizer-BioNTech partnership was announced, the companies said that they expect BioNTech's COVID-9 mRNA vaccine can
Show less
Read more
Impact Snapshot
Event Time:
BNTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BNTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BNTX alerts
High impacting BioNTech SE - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
BNTX
News
- BioNTech (NASDAQ:BNTX) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc.. They now have a $151.00 price target on the stock.MarketBeat
- BioNTech Achieves Minimum Condition in CureVac Exchange OfferGlobeNewswire
- BioNTech Shares Progress on Exchange Offer for CureVac Shares and Highlights December 3, 2025, at 9:00 a.m. Eastern Time ExpirationGlobeNewswire
- BioNTech (NASDAQ:BNTX) had its "buy" rating reaffirmed by analysts at Berenberg Bank.MarketBeat
- BioNTech (NASDAQ:BNTX) had its "buy" rating reaffirmed by analysts at Berenberg Bank.MarketBeat
BNTX
Earnings
- 11/3/25 - Miss
BNTX
Sec Filings
- 12/3/25 - Form 6-K
- 11/28/25 - Form 144
- 11/26/25 - Form 6-K
- BNTX's page on the SEC website